Ticagrelor Treatment for Prevention of Cardiovascular Events in High Risk Post Myocardial Infarction Patients- Cost-Effectiveness Analysis Using Evidence From The Pegasus-Timi 54 Trial
Abstract
Authors
P Moore A Briggs A Davies M Sculpher K Kun EA Magnuson DJ Cohen C Mellstrom